195 related articles for article (PubMed ID: 21715332)
1. Identification of arrestin-3-specific residues necessary for JNK3 kinase activation.
Seo J; Tsakem EL; Breitman M; Gurevich VV
J Biol Chem; 2011 Aug; 286(32):27894-901. PubMed ID: 21715332
[TBL] [Abstract][Full Text] [Related]
2. The beta-arrestin-2 scaffold protein promotes c-Jun N-terminal kinase-3 activation by binding to its nonconserved N terminus.
Guo C; Whitmarsh AJ
J Biol Chem; 2008 Jun; 283(23):15903-11. PubMed ID: 18408005
[TBL] [Abstract][Full Text] [Related]
3. Silent scaffolds: inhibition OF c-Jun N-terminal kinase 3 activity in cell by dominant-negative arrestin-3 mutant.
Breitman M; Kook S; Gimenez LE; Lizama BN; Palazzo MC; Gurevich EV; Gurevich VV
J Biol Chem; 2012 Jun; 287(23):19653-64. PubMed ID: 22523077
[TBL] [Abstract][Full Text] [Related]
4. How does arrestin assemble MAPKs into a signaling complex?
Song X; Coffa S; Fu H; Gurevich VV
J Biol Chem; 2009 Jan; 284(1):685-695. PubMed ID: 19001375
[TBL] [Abstract][Full Text] [Related]
5. Dynamic interaction between the dual specificity phosphatase MKP7 and the JNK3 scaffold protein beta-arrestin 2.
Willoughby EA; Collins MK
J Biol Chem; 2005 Jul; 280(27):25651-8. PubMed ID: 15888437
[TBL] [Abstract][Full Text] [Related]
6. Arrestin-3 binds c-Jun N-terminal kinase 1 (JNK1) and JNK2 and facilitates the activation of these ubiquitous JNK isoforms in cells via scaffolding.
Kook S; Zhan X; Kaoud TS; Dalby KN; Gurevich VV; Gurevich EV
J Biol Chem; 2013 Dec; 288(52):37332-42. PubMed ID: 24257757
[TBL] [Abstract][Full Text] [Related]
7. Beta-arrestin 2: a receptor-regulated MAPK scaffold for the activation of JNK3.
McDonald PH; Chow CW; Miller WE; Laporte SA; Field ME; Lin FT; Davis RJ; Lefkowitz RJ
Science; 2000 Nov; 290(5496):1574-7. PubMed ID: 11090355
[TBL] [Abstract][Full Text] [Related]
8. Identification of a motif in the carboxyl terminus of beta -arrestin2 responsible for activation of JNK3.
Miller WE; McDonald PH; Cai SF; Field ME; Davis RJ; Lefkowitz RJ
J Biol Chem; 2001 Jul; 276(30):27770-7. PubMed ID: 11356842
[TBL] [Abstract][Full Text] [Related]
9. JNK3 enzyme binding to arrestin-3 differentially affects the recruitment of upstream mitogen-activated protein (MAP) kinase kinases.
Zhan X; Kaoud TS; Kook S; Dalby KN; Gurevich VV
J Biol Chem; 2013 Oct; 288(40):28535-47. PubMed ID: 23960075
[TBL] [Abstract][Full Text] [Related]
10. Peptide mini-scaffold facilitates JNK3 activation in cells.
Zhan X; Stoy H; Kaoud TS; Perry NA; Chen Q; Perez A; Els-Heindl S; Slagis JV; Iverson TM; Beck-Sickinger AG; Gurevich EV; Dalby KN; Gurevich VV
Sci Rep; 2016 Feb; 6():21025. PubMed ID: 26868142
[TBL] [Abstract][Full Text] [Related]
11. Arrestin-dependent activation of JNK family kinases.
Zhan X; Kook S; Gurevich EV; Gurevich VV
Handb Exp Pharmacol; 2014; 219():259-80. PubMed ID: 24292834
[TBL] [Abstract][Full Text] [Related]
12. Short Arrestin-3-Derived Peptides Activate JNK3 in Cells.
Perry-Hauser NA; Kaoud TS; Stoy H; Zhan X; Chen Q; Dalby KN; Iverson TM; Gurevich VV; Gurevich EV
Int J Mol Sci; 2022 Aug; 23(15):. PubMed ID: 35955810
[TBL] [Abstract][Full Text] [Related]
13. Nonvisual arrestins function as simple scaffolds assembling the MKK4-JNK3α2 signaling complex.
Zhan X; Kaoud TS; Dalby KN; Gurevich VV
Biochemistry; 2011 Dec; 50(48):10520-9. PubMed ID: 22047447
[TBL] [Abstract][Full Text] [Related]
14. Cone arrestin binding to JNK3 and Mdm2: conformational preference and localization of interaction sites.
Song X; Gurevich EV; Gurevich VV
J Neurochem; 2007 Nov; 103(3):1053-62. PubMed ID: 17680991
[TBL] [Abstract][Full Text] [Related]
15. Arrestin-3 binds the MAP kinase JNK3α2 via multiple sites on both domains.
Zhan X; Perez A; Gimenez LE; Vishnivetskiy SA; Gurevich VV
Cell Signal; 2014 Apr; 26(4):766-76. PubMed ID: 24412749
[TBL] [Abstract][Full Text] [Related]
16. Structural Mechanism of the Arrestin-3/JNK3 Interaction.
Park JY; Qu CX; Li RR; Yang F; Yu X; Tian ZM; Shen YM; Cai BY; Yun Y; Sun JP; Chung KY
Structure; 2019 Jul; 27(7):1162-1170.e3. PubMed ID: 31080119
[TBL] [Abstract][Full Text] [Related]
17. Arrestin-3 scaffolding of the JNK3 cascade suggests a mechanism for signal amplification.
Perry NA; Kaoud TS; Ortega OO; Kaya AI; Marcus DJ; Pleinis JM; Berndt S; Chen Q; Zhan X; Dalby KN; Lopez CF; Iverson TM; Gurevich VV
Proc Natl Acad Sci U S A; 2019 Jan; 116(3):810-815. PubMed ID: 30591558
[TBL] [Abstract][Full Text] [Related]
18. Small peptide inhibitor of JNK3 protects dopaminergic neurons from MPTP induced injury via inhibiting the ASK1-JNK3 signaling pathway.
Pan J; Li H; Zhang B; Xiong R; Zhang Y; Kang WY; Chen W; Zhao ZB; Chen SD
PLoS One; 2015; 10(4):e0119204. PubMed ID: 25856433
[TBL] [Abstract][Full Text] [Related]
19. GPCR Binding and JNK3 Activation by Arrestin-3 Have Different Structural Requirements.
Zheng C; Weinstein LD; Nguyen KK; Grewal A; Gurevich EV; Gurevich VV
Cells; 2023 Jun; 12(12):. PubMed ID: 37371033
[TBL] [Abstract][Full Text] [Related]
20. A scanning peptide array approach uncovers association sites within the JNK/beta arrestin signalling complex.
Li X; MacLeod R; Dunlop AJ; Edwards HV; Advant N; Gibson LC; Devine NM; Brown KM; Adams DR; Houslay MD; Baillie GS
FEBS Lett; 2009 Oct; 583(20):3310-6. PubMed ID: 19782076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
